MedTrace Logo

Ultra-low Dose Contrast for Endovascular Procedures

NCT06835127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2026-03-10

No results posted yet for this study

Summary

The purpose of this protocol is to study the safety and feasibility of using ultra-low dose iodinated contrast agent for infrainguinal endovascular revascularization procedures in patients with chronic limb-threatening lower limb ischemia (CLTI) and impaired renal function, in the new angiography suite of our department.

Conditions

  • Renal Impairment
  • Limb Ischemia, Critical

Interventions

PROCEDURE

Infrainguinal peripheral endovascular revascularization

Percutaneous endovascular angioplasty and/or stenting of infrainguinal arteries (femoropopliteal and/or infrapopliteal arteries) under local anesthesia and adjunct mild conscious sedation.

Sponsors & Collaborators

  • Attikon Hospital

    lead OTHER

Principal Investigators

  • Stavros C Spiliopoulos, MD, PhD · ATTIKO University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2026-01-23
Completion
2026-01-23

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06835127 on ClinicalTrials.gov